Ulrich Dirnagl appointed first chair of the Center for Transforming Biomedical Research
Berlin Institute of Health (BIH) is offering the first chairs who will play a central role at BIH as the founding directors of new centers dedicated to key research areas. Five W3 professorship appointments were announced in the fields of digital health, clinical translational sciences, disease modeling, genomic medicine, and cell and gene therapy. These are joint appointments with Charité – Universitätsmedizin Berlin and are part of a fast-track procedure. In addition, Professor Ulrich Dirnagl was appointed first chair of the Center for Transforming Biomedical Research.
This center is a new unit that will focus on strengthening quality assurance and generalizability of results as well as providing access to research including methods, results, and data. BIH research should be transparent and reliable. Since March, the center is led by Professor Ulrich Dirnagl – a neurologist and stroke researcher at Charité. Ensuring quality standards and reproducibility in biomedical research has been a key aspect of Dirnagl’s scientific work for many years.
Dirnagl studied medicine at LMU Munich, where he worked as a research assistant in the Department of Neurology before transferring to Cornell University in the United States. He came to Charité in 1993, where he was appointed director of the Department of Experimental Neurology in 1999. His additional roles include member of the Board of Directors for the NeuroCure Cluster of Excellence, and the Center for Stroke Research Berlin (CSB).